Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 02 - 15 tags : Iot save search
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-02-15 (Crawled : 23:00) - biospace.com/
ADPT | $2.52 5.0% 4.76% 2.1M
|
Commercial Services
|
| O: 3.0%
H: 1.86%
C: -2.78%
financial results report results biotech iot
Cumulus Wilmington’s WGNI-FM, WMNX-FM and WWQQ-FM Raise $60,975 in 26-Hour Radiothon for St. Jude Children’s Research Hospital
Published: 2022-02-15 (Crawled : 23:00) - cumulusmedia.com
CMLS | $2.78 -7.02% -7.55% 130K
|
Consumer Services
|
| O: -1.17%
H: 2.37%
C: 1.19%
research children iot
Insights on the Agricultural Biotechnology for Transgenic Crops Global Market to 2026 - Featuring Agrilife, Bayer and Evogene Among Others
Published: 2022-02-15 (Crawled : 16:00) - prnewswire.com
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: 1.63%
H: 3.2%
C: 1.6%
technology agricultural biotech iot drop
Legend Biotech Announces FDA Clinical Hold of its Phase 1 Clinical Trial for LB1901
Published: 2022-02-15 (Crawled : 15:30) - biospace.com/
LEGN | News | $47.07 1.91% 1.87% 750K
|
Health Technology
|
| O: -4.15%
H: 6.75%
C: 6.65%
lb1901 clinical hold fda trial phase 1 biotech iot phase 2 phase 3
AXIM Biotech Announces New Milestones in Preparation of Dry Eye Disease Diagnostics Launch
Published: 2022-02-15 (Crawled : 14:30) - globenewswire.com
AXIM | $0.015 -6.67% 170K
|
Manufacturing
|
| O: 6.79%
H: 0.0%
C: -3.34%
diagnostic dry eye eye eye disease diagnostics disease one biotech axim iot milestone
PDS Biotech Announces Clinical Trial with Mayo Clinic to Study PDS0101 in Early Stage Pre-Metastatic- HPV-Associated Head and Neck Cancer
Published: 2022-02-15 (Crawled : 14:30) - biospace.com/
PDSB | $2.99 13.04% 11.54% 680K
|
Health Technology
|
| O: 2.78%
H: 4.42%
C: -1.71%
pds0101 ces hpv trial cancer head and neck biotech iot
Portage Biotech Announces New Appointments to its Management Team and Board of Directors
Published: 2022-02-15 (Crawled : 14:30) - globenewswire.com
PRTG | $0.3035 11.99% 10.71% 420K
|
Mining, Quarrying, and Oil and ...
|
| O: 3.67%
H: 11.84%
C: 7.94%
XYF | News | $3.875 2.51% 0.65% 6K
|
Finance
|
| O: -2.13%
H: 6.83%
C: 5.28%
RAPT | $7.86 -1.13% -1.15% 380K
|
Health Technology
|
| O: 3.04%
H: 4.5%
C: 3.36%
ces biotech iot
ImmunityBio Completes Acquisition of Athenex’s Interest in Dunkirk, New York Advanced Biotech Manufacturing Facility
Published: 2022-02-15 (Crawled : 14:00) - nantkwest.com
IBRX | $4.945 -6.17% -6.57% 4.2M
|
Manufacturing
|
| O: 9.91%
H: 12.66%
C: 11.23%
ATNX | $0.2031 -7.78% 1.9M
|
Health Technology
|
| O: 1.84%
H: 9.2%
C: 4.91%
acquisition biotech iot
Last Patient Completes Treatment in Stealth BioTherapeutics' Phase 2 Geographic Atrophy Clinical Trial
Published: 2022-02-15 (Crawled : 13:30) - biospace.com/
MITO | $0.32 0.25%
|
Health Technology
|
| O: 0.64%
H: 11.11%
C: 3.16%
treatment phase 2 trial therapeutics iot
Interim Findings from MIRAGE Phase III Randomized Trial Signal Superiority of MRIdian® MRI-guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer
Published: 2022-02-15 (Crawled : 12:00) - prnewswire.com
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
|
| O: 3.4%
H: 1.1%
C: -7.24%
mridian prostate cancer state trial therapy cancer iot
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.